Literature DB >> 22519683

Development and validation of a prediction model for low hemoglobin deferral in a large cohort of whole blood donors.

A Mireille Baart1, Wim L A M de Kort, Femke Atsma, Karel G M Moons, Yvonne Vergouwe.   

Abstract

BACKGROUND: Each year, approximately 5% of the invited blood donors is eventually deferred from donation because of low hemoglobin (Hb) levels. Estimating the risk of Hb deferral in blood donors can be helpful in the management of the donation program. We developed and validated a prediction model for Hb deferral in whole blood donors, separately for men and women. STUDY DESIGN AND METHODS: Data from a Dutch prospective cohort of 220,946 whole blood donors were used to identify predictors for Hb deferral using multivariable logistic regression analyses. Validity of the prediction models was assessed with a cross-validation.
RESULTS: A total of 12,865 donors (5.8%) were deferred because of a low Hb level. The strongest predictors of Hb deferral were Hb level measured at the previous visit, age, seasonality, difference in Hb levels between the previous two visits, time since the previous visit, deferral at the previous visit, and the total number of whole blood donations in the past 2 years for both men and women. The prediction models had an area under the receiver operating characteristic curve of 0.89 for men and 0.84 for women. Cross-validation showed similar results and good calibration.
CONCLUSION: Using a limited number of easy-to-measure characteristics enables a good prediction of Hb deferral risk in whole blood donors. The prediction models may guide the decision which donors to invite for a next donation and for which donors the invitation should be postponed. Potentially, this could decrease the number of Hb deferrals in blood donors.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22519683     DOI: 10.1111/j.1537-2995.2012.03655.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Unexpected predictor-outcome associations in clinical prediction research: causes and solutions.

Authors:  Ewoud Schuit; Rolf H H Groenwold; Frank E Harrell; Wim L A M de Kort; Anneke Kwee; Ben Willem J Mol; Richard D Riley; Karel G M Moons
Journal:  CMAJ       Date:  2013-01-21       Impact factor: 8.262

Review 2.  Donor research in australia: challenges and promise.

Authors:  Barbara Masser; Geoff Smith; Lisa A Williams
Journal:  Transfus Med Hemother       Date:  2014-07-04       Impact factor: 3.747

Review 3.  Low hemoglobin deferral in blood donors.

Authors:  Alan E Mast
Journal:  Transfus Med Rev       Date:  2013-11-12

4.  Generalizability of Dutch Prediction Models for Low Hemoglobin Deferral: A Study on External Validation and Updating in Swiss Whole Blood Donors.

Authors:  A Mireille Baart; Stefano Fontana; Anita Tschaggelar; Martijn W Heymans; Wim L A M de Kort
Journal:  Transfus Med Hemother       Date:  2016-10-14       Impact factor: 3.747

5.  Anemia and the blood donor.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Validating and updating a risk model for pneumonia - a case study.

Authors:  Ulrike Held; Daniel Sabanes Bové; Johann Steurer; Leonhard Held
Journal:  BMC Med Res Methodol       Date:  2012-07-20       Impact factor: 4.615

7.  Prediction and impact of personalized donation intervals.

Authors:  Jarkko Toivonen; Yrjö Koski; Esa Turkulainen; Femmeke Prinsze; Pietro Della Briotta Parolo; Markus Heinonen; Mikko Arvas
Journal:  Vox Sang       Date:  2021-11-26       Impact factor: 2.996

8.  Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study.

Authors:  Sara Moazzen; Maike G Sweegers; Mart Janssen; Boris M Hogema; Trynke Hoekstra; Katja Van den Hurk
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

9.  Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models.

Authors:  Kazem Nasserinejad; Wim de Kort; Mireille Baart; Arnošt Komárek; Joost van Rosmalen; Emmanuel Lesaffre
Journal:  BMC Med Res Methodol       Date:  2013-05-02       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.